Childhood CML in India: b2a2 transcript is more common than b3a2.
about
Pediatric chronic myeloid leukemia is a unique disease that requires a different approachThe impact of early molecular response in children and adolescents with chronic myeloid leukemia treated with imatinib: a single-center study from China.Comparative Study of Clinico-hematological Features, Molecular Spectrum and Response to Imatinib in Chronic Myelogenous Leukemia Patients: Pediatric and Adolescent Versus Adults.Differences among young adults, adults and elderly chronic myeloid leukemia patients.
P2860
Childhood CML in India: b2a2 transcript is more common than b3a2.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Childhood CML in India: b2a2 transcript is more common than b3a2.
@en
Childhood CML in India: b2a2 transcript is more common than b3a2.
@nl
type
label
Childhood CML in India: b2a2 transcript is more common than b3a2.
@en
Childhood CML in India: b2a2 transcript is more common than b3a2.
@nl
prefLabel
Childhood CML in India: b2a2 transcript is more common than b3a2.
@en
Childhood CML in India: b2a2 transcript is more common than b3a2.
@nl
P2093
P1476
Childhood CML in India: b2a2 transcript is more common than b3a2.
@en
P2093
Bijender Kumar
Pravas Mishra
Rashid Mir
Rekha Chaubey
Renu Saxena
Sudha Sazawal
Syed Khizer Hasan
Ved Prakash Chaudhry
P356
10.1016/J.CANCERGENCYTO.2006.01.015
P577
2006-08-01T00:00:00Z